Clinical Trial Update: A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of teduglutide in Japanese children aged 4 months and older with Short Bowel Syndrome has completed, with results posted on May 16, 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• GATTEX (teduglutide)

Snippet

Sponsor: Takeda | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-05-16